Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Germany Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20042
20052
20063
20071
20094
20112
20135
20142
20152
20183
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated3
Active, not recruiting2
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices2
AstraZeneca2
Bayer2
Boston Scientific Corporation2
Cordis US Corp.2
Air Liquide Santé International1
Alexion Pharmaceuticals, Inc.1
Amgen1
Bracco Diagnostics, Inc1
CSL Behring1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease32
Myocardial Infarction5
Myocardial Ischemia5
Acute Coronary Syndrome4
Heart Diseases4
Cardiovascular Diseases3
Diabetes Mellitus, Type 23
Peripheral Arterial Disease3
Stroke3
Vascular Diseases3

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.